nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—CYP3A4—bone cancer	0.794	1	CbGaD
Clonazepam—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.00141	0.128	CbGpPWpGaD
Clonazepam—NAT2—Metapathway biotransformation—CYP4V2—bone cancer	0.000942	0.0856	CbGpPWpGaD
Clonazepam—Bromazepam—CYP3A4—bone cancer	0.000526	0.0953	CrCbGaD
Clonazepam—Clorazepate—CYP3A4—bone cancer	0.000478	0.0866	CrCbGaD
Clonazepam—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000464	0.0422	CbGpPWpGaD
Clonazepam—Clotiazepam—CYP3A4—bone cancer	0.000458	0.083	CrCbGaD
Clonazepam—Alprazolam—CYP3A4—bone cancer	0.000433	0.0784	CrCbGaD
Clonazepam—Quazepam—CYP3A4—bone cancer	0.000419	0.076	CrCbGaD
Clonazepam—Flunitrazepam—CYP3A4—bone cancer	0.000396	0.0718	CrCbGaD
Clonazepam—Estazolam—CYP3A4—bone cancer	0.00037	0.0671	CrCbGaD
Clonazepam—Nasopharyngitis—Doxorubicin—bone cancer	0.000362	0.00191	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Cisplatin—bone cancer	0.000362	0.00191	CcSEcCtD
Clonazepam—Drowsiness—Methotrexate—bone cancer	0.00036	0.00191	CcSEcCtD
Clonazepam—Depression—Methotrexate—bone cancer	0.000359	0.0019	CcSEcCtD
Clonazepam—Gastritis—Doxorubicin—bone cancer	0.000358	0.00189	CcSEcCtD
Clonazepam—Pain—Cisplatin—bone cancer	0.000358	0.00189	CcSEcCtD
Clonazepam—Nitrazepam—CYP3A4—bone cancer	0.000358	0.0648	CrCbGaD
Clonazepam—Muscular weakness—Doxorubicin—bone cancer	0.000357	0.00189	CcSEcCtD
Clonazepam—Dysuria—Epirubicin—bone cancer	0.000354	0.00187	CcSEcCtD
Clonazepam—Upper respiratory tract infection—Epirubicin—bone cancer	0.000351	0.00186	CcSEcCtD
Clonazepam—Asthma—Doxorubicin—bone cancer	0.00035	0.00185	CcSEcCtD
Clonazepam—Dysphagia—Doxorubicin—bone cancer	0.00035	0.00185	CcSEcCtD
Clonazepam—Influenza—Doxorubicin—bone cancer	0.00035	0.00185	CcSEcCtD
Clonazepam—Pollakiuria—Epirubicin—bone cancer	0.000349	0.00185	CcSEcCtD
Clonazepam—Eosinophilia—Doxorubicin—bone cancer	0.000346	0.00183	CcSEcCtD
Clonazepam—Feeling abnormal—Cisplatin—bone cancer	0.000345	0.00182	CcSEcCtD
Clonazepam—Weight increased—Epirubicin—bone cancer	0.000344	0.00182	CcSEcCtD
Clonazepam—Weight decreased—Epirubicin—bone cancer	0.000342	0.00181	CcSEcCtD
Clonazepam—Prazepam—CYP3A4—bone cancer	0.000341	0.0618	CrCbGaD
Clonazepam—Epistaxis—Methotrexate—bone cancer	0.00034	0.0018	CcSEcCtD
Clonazepam—Pneumonia—Epirubicin—bone cancer	0.000339	0.00179	CcSEcCtD
Clonazepam—Drowsiness—Epirubicin—bone cancer	0.000337	0.00178	CcSEcCtD
Clonazepam—Bronchitis—Doxorubicin—bone cancer	0.000337	0.00178	CcSEcCtD
Clonazepam—Body temperature increased—Cisplatin—bone cancer	0.000331	0.00175	CcSEcCtD
Clonazepam—Neuropathy peripheral—Epirubicin—bone cancer	0.000331	0.00175	CcSEcCtD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—FEV—bone cancer	0.000329	0.0299	CbGpPWpGaD
Clonazepam—Urinary tract infection—Epirubicin—bone cancer	0.000328	0.00173	CcSEcCtD
Clonazepam—Dysuria—Doxorubicin—bone cancer	0.000327	0.00173	CcSEcCtD
Clonazepam—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000325	0.00172	CcSEcCtD
Clonazepam—Haemoglobin—Methotrexate—bone cancer	0.000325	0.00172	CcSEcCtD
Clonazepam—Haemorrhage—Methotrexate—bone cancer	0.000323	0.00171	CcSEcCtD
Clonazepam—Pollakiuria—Doxorubicin—bone cancer	0.000323	0.00171	CcSEcCtD
Clonazepam—Pharyngitis—Methotrexate—bone cancer	0.000321	0.0017	CcSEcCtD
Clonazepam—Urinary tract disorder—Methotrexate—bone cancer	0.000319	0.00169	CcSEcCtD
Clonazepam—Weight increased—Doxorubicin—bone cancer	0.000318	0.00168	CcSEcCtD
Clonazepam—ALB—Folate Metabolism—FOLR1—bone cancer	0.000318	0.0289	CbGpPWpGaD
Clonazepam—Epistaxis—Epirubicin—bone cancer	0.000318	0.00168	CcSEcCtD
Clonazepam—Flurazepam—CYP3A4—bone cancer	0.000318	0.0576	CrCbGaD
Clonazepam—Triazolam—CYP3A4—bone cancer	0.000317	0.0575	CrCbGaD
Clonazepam—Urethral disorder—Methotrexate—bone cancer	0.000317	0.00168	CcSEcCtD
Clonazepam—Weight decreased—Doxorubicin—bone cancer	0.000317	0.00167	CcSEcCtD
Clonazepam—Sinusitis—Epirubicin—bone cancer	0.000316	0.00167	CcSEcCtD
Clonazepam—Pneumonia—Doxorubicin—bone cancer	0.000314	0.00166	CcSEcCtD
Clonazepam—Drowsiness—Doxorubicin—bone cancer	0.000312	0.00165	CcSEcCtD
Clonazepam—Visual impairment—Methotrexate—bone cancer	0.000312	0.00165	CcSEcCtD
Clonazepam—Hypersensitivity—Cisplatin—bone cancer	0.000309	0.00163	CcSEcCtD
Clonazepam—Oxazepam—CYP3A4—bone cancer	0.000308	0.0558	CrCbGaD
Clonazepam—Neuropathy peripheral—Doxorubicin—bone cancer	0.000306	0.00162	CcSEcCtD
Clonazepam—Haemoglobin—Epirubicin—bone cancer	0.000304	0.00161	CcSEcCtD
Clonazepam—Rhinitis—Epirubicin—bone cancer	0.000303	0.0016	CcSEcCtD
Clonazepam—Urinary tract infection—Doxorubicin—bone cancer	0.000303	0.0016	CcSEcCtD
Clonazepam—Haemorrhage—Epirubicin—bone cancer	0.000303	0.0016	CcSEcCtD
Clonazepam—Eye disorder—Methotrexate—bone cancer	0.000302	0.0016	CcSEcCtD
Clonazepam—Hypoaesthesia—Epirubicin—bone cancer	0.000301	0.00159	CcSEcCtD
Clonazepam—Asthenia—Cisplatin—bone cancer	0.0003	0.00159	CcSEcCtD
Clonazepam—Pharyngitis—Epirubicin—bone cancer	0.0003	0.00159	CcSEcCtD
Clonazepam—Cardiac disorder—Methotrexate—bone cancer	0.0003	0.00159	CcSEcCtD
Clonazepam—Urinary tract disorder—Epirubicin—bone cancer	0.000299	0.00158	CcSEcCtD
Clonazepam—Oedema peripheral—Epirubicin—bone cancer	0.000298	0.00158	CcSEcCtD
Clonazepam—Connective tissue disorder—Epirubicin—bone cancer	0.000297	0.00157	CcSEcCtD
Clonazepam—Urethral disorder—Epirubicin—bone cancer	0.000297	0.00157	CcSEcCtD
Clonazepam—Midazolam—CYP3A4—bone cancer	0.000295	0.0534	CrCbGaD
Clonazepam—Epistaxis—Doxorubicin—bone cancer	0.000294	0.00156	CcSEcCtD
Clonazepam—Sinusitis—Doxorubicin—bone cancer	0.000293	0.00155	CcSEcCtD
Clonazepam—Immune system disorder—Methotrexate—bone cancer	0.000292	0.00154	CcSEcCtD
Clonazepam—Visual impairment—Epirubicin—bone cancer	0.000292	0.00154	CcSEcCtD
Clonazepam—Chills—Methotrexate—bone cancer	0.00029	0.00153	CcSEcCtD
Clonazepam—Diarrhoea—Cisplatin—bone cancer	0.000287	0.00152	CcSEcCtD
Clonazepam—Alopecia—Methotrexate—bone cancer	0.000286	0.00151	CcSEcCtD
Clonazepam—Mental disorder—Methotrexate—bone cancer	0.000283	0.0015	CcSEcCtD
Clonazepam—Eye disorder—Epirubicin—bone cancer	0.000283	0.0015	CcSEcCtD
Clonazepam—Malnutrition—Methotrexate—bone cancer	0.000282	0.00149	CcSEcCtD
Clonazepam—Haemoglobin—Doxorubicin—bone cancer	0.000281	0.00149	CcSEcCtD
Clonazepam—Cardiac disorder—Epirubicin—bone cancer	0.000281	0.00149	CcSEcCtD
Clonazepam—Flushing—Epirubicin—bone cancer	0.000281	0.00149	CcSEcCtD
Clonazepam—Rhinitis—Doxorubicin—bone cancer	0.000281	0.00148	CcSEcCtD
Clonazepam—Haemorrhage—Doxorubicin—bone cancer	0.00028	0.00148	CcSEcCtD
Clonazepam—Hypoaesthesia—Doxorubicin—bone cancer	0.000279	0.00147	CcSEcCtD
Clonazepam—Pharyngitis—Doxorubicin—bone cancer	0.000278	0.00147	CcSEcCtD
Clonazepam—Urinary tract disorder—Doxorubicin—bone cancer	0.000277	0.00146	CcSEcCtD
Clonazepam—NAT2—Phase II conjugation—GSTP1—bone cancer	0.000276	0.0251	CbGpPWpGaD
Clonazepam—Oedema peripheral—Doxorubicin—bone cancer	0.000276	0.00146	CcSEcCtD
Clonazepam—Connective tissue disorder—Doxorubicin—bone cancer	0.000275	0.00146	CcSEcCtD
Clonazepam—Urethral disorder—Doxorubicin—bone cancer	0.000275	0.00145	CcSEcCtD
Clonazepam—Immune system disorder—Epirubicin—bone cancer	0.000273	0.00145	CcSEcCtD
Clonazepam—Back pain—Methotrexate—bone cancer	0.000272	0.00144	CcSEcCtD
Clonazepam—Chills—Epirubicin—bone cancer	0.000272	0.00144	CcSEcCtD
Clonazepam—Visual impairment—Doxorubicin—bone cancer	0.00027	0.00143	CcSEcCtD
Clonazepam—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000268	0.0243	CbGpPWpGaD
Clonazepam—Alopecia—Epirubicin—bone cancer	0.000267	0.00141	CcSEcCtD
Clonazepam—Vomiting—Cisplatin—bone cancer	0.000266	0.00141	CcSEcCtD
Clonazepam—Vision blurred—Methotrexate—bone cancer	0.000265	0.0014	CcSEcCtD
Clonazepam—Mental disorder—Epirubicin—bone cancer	0.000265	0.0014	CcSEcCtD
Clonazepam—Rash—Cisplatin—bone cancer	0.000264	0.0014	CcSEcCtD
Clonazepam—Dermatitis—Cisplatin—bone cancer	0.000264	0.00139	CcSEcCtD
Clonazepam—Malnutrition—Epirubicin—bone cancer	0.000263	0.00139	CcSEcCtD
Clonazepam—Eye disorder—Doxorubicin—bone cancer	0.000262	0.00138	CcSEcCtD
Clonazepam—Ill-defined disorder—Methotrexate—bone cancer	0.000261	0.00138	CcSEcCtD
Clonazepam—Anaemia—Methotrexate—bone cancer	0.00026	0.00138	CcSEcCtD
Clonazepam—Flushing—Doxorubicin—bone cancer	0.00026	0.00137	CcSEcCtD
Clonazepam—Cardiac disorder—Doxorubicin—bone cancer	0.00026	0.00137	CcSEcCtD
Clonazepam—Flatulence—Epirubicin—bone cancer	0.00026	0.00137	CcSEcCtD
Clonazepam—Tension—Epirubicin—bone cancer	0.000259	0.00137	CcSEcCtD
Clonazepam—Nervousness—Epirubicin—bone cancer	0.000256	0.00135	CcSEcCtD
Clonazepam—Back pain—Epirubicin—bone cancer	0.000255	0.00135	CcSEcCtD
Clonazepam—Malaise—Methotrexate—bone cancer	0.000254	0.00134	CcSEcCtD
Clonazepam—Muscle spasms—Epirubicin—bone cancer	0.000253	0.00134	CcSEcCtD
Clonazepam—Immune system disorder—Doxorubicin—bone cancer	0.000253	0.00134	CcSEcCtD
Clonazepam—Vertigo—Methotrexate—bone cancer	0.000253	0.00134	CcSEcCtD
Clonazepam—Diazepam—CYP3A4—bone cancer	0.000253	0.0458	CrCbGaD
Clonazepam—Leukopenia—Methotrexate—bone cancer	0.000252	0.00133	CcSEcCtD
Clonazepam—Chills—Doxorubicin—bone cancer	0.000251	0.00133	CcSEcCtD
Clonazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000251	0.0228	CbGpPWpGaD
Clonazepam—Clozapine—CYP3A4—bone cancer	0.000249	0.0452	CrCbGaD
Clonazepam—Nausea—Cisplatin—bone cancer	0.000249	0.00132	CcSEcCtD
Clonazepam—Vision blurred—Epirubicin—bone cancer	0.000248	0.00131	CcSEcCtD
Clonazepam—Alopecia—Doxorubicin—bone cancer	0.000247	0.00131	CcSEcCtD
Clonazepam—Cough—Methotrexate—bone cancer	0.000246	0.0013	CcSEcCtD
Clonazepam—Mental disorder—Doxorubicin—bone cancer	0.000245	0.0013	CcSEcCtD
Clonazepam—Ill-defined disorder—Epirubicin—bone cancer	0.000244	0.00129	CcSEcCtD
Clonazepam—Malnutrition—Doxorubicin—bone cancer	0.000244	0.00129	CcSEcCtD
Clonazepam—Anaemia—Epirubicin—bone cancer	0.000244	0.00129	CcSEcCtD
Clonazepam—Agitation—Epirubicin—bone cancer	0.000242	0.00128	CcSEcCtD
Clonazepam—Flatulence—Doxorubicin—bone cancer	0.00024	0.00127	CcSEcCtD
Clonazepam—Myalgia—Methotrexate—bone cancer	0.00024	0.00127	CcSEcCtD
Clonazepam—Arthralgia—Methotrexate—bone cancer	0.00024	0.00127	CcSEcCtD
Clonazepam—Chest pain—Methotrexate—bone cancer	0.00024	0.00127	CcSEcCtD
Clonazepam—Tension—Doxorubicin—bone cancer	0.000239	0.00127	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000238	0.00126	CcSEcCtD
Clonazepam—Malaise—Epirubicin—bone cancer	0.000238	0.00126	CcSEcCtD
Clonazepam—Discomfort—Methotrexate—bone cancer	0.000237	0.00125	CcSEcCtD
Clonazepam—Nervousness—Doxorubicin—bone cancer	0.000237	0.00125	CcSEcCtD
Clonazepam—Vertigo—Epirubicin—bone cancer	0.000237	0.00125	CcSEcCtD
Clonazepam—GABRB2—Orphan transporters—TUBB4B—bone cancer	0.000236	0.0215	CbGpPWpGaD
Clonazepam—Leukopenia—Epirubicin—bone cancer	0.000236	0.00125	CcSEcCtD
Clonazepam—Back pain—Doxorubicin—bone cancer	0.000236	0.00125	CcSEcCtD
Clonazepam—Muscle spasms—Doxorubicin—bone cancer	0.000234	0.00124	CcSEcCtD
Clonazepam—Palpitations—Epirubicin—bone cancer	0.000233	0.00123	CcSEcCtD
Clonazepam—Confusional state—Methotrexate—bone cancer	0.000232	0.00123	CcSEcCtD
Clonazepam—Cough—Epirubicin—bone cancer	0.00023	0.00122	CcSEcCtD
Clonazepam—Anaphylactic shock—Methotrexate—bone cancer	0.00023	0.00122	CcSEcCtD
Clonazepam—Vision blurred—Doxorubicin—bone cancer	0.00023	0.00122	CcSEcCtD
Clonazepam—Infection—Methotrexate—bone cancer	0.000228	0.00121	CcSEcCtD
Clonazepam—Ill-defined disorder—Doxorubicin—bone cancer	0.000226	0.0012	CcSEcCtD
Clonazepam—Nervous system disorder—Methotrexate—bone cancer	0.000225	0.00119	CcSEcCtD
Clonazepam—Anaemia—Doxorubicin—bone cancer	0.000225	0.00119	CcSEcCtD
Clonazepam—GABRA3—Orphan transporters—TUBB4B—bone cancer	0.000225	0.0205	CbGpPWpGaD
Clonazepam—Thrombocytopenia—Methotrexate—bone cancer	0.000225	0.00119	CcSEcCtD
Clonazepam—Myalgia—Epirubicin—bone cancer	0.000224	0.00119	CcSEcCtD
Clonazepam—Arthralgia—Epirubicin—bone cancer	0.000224	0.00119	CcSEcCtD
Clonazepam—Chest pain—Epirubicin—bone cancer	0.000224	0.00119	CcSEcCtD
Clonazepam—Agitation—Doxorubicin—bone cancer	0.000224	0.00118	CcSEcCtD
Clonazepam—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.000224	0.0203	CbGpPWpGaD
Clonazepam—Anxiety—Epirubicin—bone cancer	0.000224	0.00118	CcSEcCtD
Clonazepam—Skin disorder—Methotrexate—bone cancer	0.000223	0.00118	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000223	0.00118	CcSEcCtD
Clonazepam—Discomfort—Epirubicin—bone cancer	0.000222	0.00117	CcSEcCtD
Clonazepam—Malaise—Doxorubicin—bone cancer	0.00022	0.00116	CcSEcCtD
Clonazepam—Dry mouth—Epirubicin—bone cancer	0.000219	0.00116	CcSEcCtD
Clonazepam—Vertigo—Doxorubicin—bone cancer	0.000219	0.00116	CcSEcCtD
Clonazepam—Anorexia—Methotrexate—bone cancer	0.000219	0.00116	CcSEcCtD
Clonazepam—Leukopenia—Doxorubicin—bone cancer	0.000218	0.00115	CcSEcCtD
Clonazepam—Confusional state—Epirubicin—bone cancer	0.000217	0.00115	CcSEcCtD
Clonazepam—GABRG2—Orphan transporters—TUBB4B—bone cancer	0.000216	0.0196	CbGpPWpGaD
Clonazepam—Palpitations—Doxorubicin—bone cancer	0.000215	0.00114	CcSEcCtD
Clonazepam—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000215	0.0196	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000215	0.0196	CbGpPWpGaD
Clonazepam—Oedema—Epirubicin—bone cancer	0.000215	0.00114	CcSEcCtD
Clonazepam—Anaphylactic shock—Epirubicin—bone cancer	0.000215	0.00114	CcSEcCtD
Clonazepam—Hypotension—Methotrexate—bone cancer	0.000215	0.00114	CcSEcCtD
Clonazepam—Infection—Epirubicin—bone cancer	0.000214	0.00113	CcSEcCtD
Clonazepam—Cough—Doxorubicin—bone cancer	0.000213	0.00113	CcSEcCtD
Clonazepam—Nervous system disorder—Epirubicin—bone cancer	0.000211	0.00112	CcSEcCtD
Clonazepam—Thrombocytopenia—Epirubicin—bone cancer	0.000211	0.00111	CcSEcCtD
Clonazepam—Tachycardia—Epirubicin—bone cancer	0.00021	0.00111	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000209	0.00111	CcSEcCtD
Clonazepam—Skin disorder—Epirubicin—bone cancer	0.000209	0.0011	CcSEcCtD
Clonazepam—Insomnia—Methotrexate—bone cancer	0.000208	0.0011	CcSEcCtD
Clonazepam—Arthralgia—Doxorubicin—bone cancer	0.000208	0.0011	CcSEcCtD
Clonazepam—Myalgia—Doxorubicin—bone cancer	0.000208	0.0011	CcSEcCtD
Clonazepam—Chest pain—Doxorubicin—bone cancer	0.000208	0.0011	CcSEcCtD
Clonazepam—Anxiety—Doxorubicin—bone cancer	0.000207	0.00109	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000206	0.00109	CcSEcCtD
Clonazepam—Discomfort—Doxorubicin—bone cancer	0.000205	0.00108	CcSEcCtD
Clonazepam—Anorexia—Epirubicin—bone cancer	0.000205	0.00108	CcSEcCtD
Clonazepam—Dyspnoea—Methotrexate—bone cancer	0.000205	0.00108	CcSEcCtD
Clonazepam—Somnolence—Methotrexate—bone cancer	0.000204	0.00108	CcSEcCtD
Clonazepam—GABRB2—Orphan transporters—TUBB2A—bone cancer	0.000204	0.0185	CbGpPWpGaD
Clonazepam—Dry mouth—Doxorubicin—bone cancer	0.000203	0.00107	CcSEcCtD
Clonazepam—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000203	0.0184	CbGpPWpGaD
Clonazepam—Dyspepsia—Methotrexate—bone cancer	0.000202	0.00107	CcSEcCtD
Clonazepam—Hypotension—Epirubicin—bone cancer	0.000201	0.00106	CcSEcCtD
Clonazepam—Confusional state—Doxorubicin—bone cancer	0.000201	0.00106	CcSEcCtD
Clonazepam—Decreased appetite—Methotrexate—bone cancer	0.0002	0.00106	CcSEcCtD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.0002	0.0181	CbGpPWpGaD
Clonazepam—Oedema—Doxorubicin—bone cancer	0.000199	0.00105	CcSEcCtD
Clonazepam—Anaphylactic shock—Doxorubicin—bone cancer	0.000199	0.00105	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Methotrexate—bone cancer	0.000198	0.00105	CcSEcCtD
Clonazepam—Fatigue—Methotrexate—bone cancer	0.000198	0.00105	CcSEcCtD
Clonazepam—Infection—Doxorubicin—bone cancer	0.000198	0.00105	CcSEcCtD
Clonazepam—Pain—Methotrexate—bone cancer	0.000197	0.00104	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000196	0.00104	CcSEcCtD
Clonazepam—Nervous system disorder—Doxorubicin—bone cancer	0.000195	0.00103	CcSEcCtD
Clonazepam—Thrombocytopenia—Doxorubicin—bone cancer	0.000195	0.00103	CcSEcCtD
Clonazepam—Insomnia—Epirubicin—bone cancer	0.000194	0.00103	CcSEcCtD
Clonazepam—GABRA3—Orphan transporters—TUBB2A—bone cancer	0.000194	0.0177	CbGpPWpGaD
Clonazepam—Tachycardia—Doxorubicin—bone cancer	0.000194	0.00103	CcSEcCtD
Clonazepam—Skin disorder—Doxorubicin—bone cancer	0.000193	0.00102	CcSEcCtD
Clonazepam—Dyspnoea—Epirubicin—bone cancer	0.000192	0.00101	CcSEcCtD
Clonazepam—Somnolence—Epirubicin—bone cancer	0.000191	0.00101	CcSEcCtD
Clonazepam—Anorexia—Doxorubicin—bone cancer	0.00019	0.001	CcSEcCtD
Clonazepam—Feeling abnormal—Methotrexate—bone cancer	0.000189	0.001	CcSEcCtD
Clonazepam—Dyspepsia—Epirubicin—bone cancer	0.000189	0.001	CcSEcCtD
Clonazepam—NAT2—Biological oxidations—CYP3A4—bone cancer	0.000189	0.0172	CbGpPWpGaD
Clonazepam—GABRA1—Orphan transporters—TUBB4B—bone cancer	0.000189	0.0171	CbGpPWpGaD
Clonazepam—Gastrointestinal pain—Methotrexate—bone cancer	0.000188	0.000994	CcSEcCtD
Clonazepam—Decreased appetite—Epirubicin—bone cancer	0.000187	0.000989	CcSEcCtD
Clonazepam—GABRG2—Orphan transporters—TUBB2A—bone cancer	0.000186	0.0169	CbGpPWpGaD
Clonazepam—NAT2—Metapathway biotransformation—CYP3A4—bone cancer	0.000186	0.0169	CbGpPWpGaD
Clonazepam—Hypotension—Doxorubicin—bone cancer	0.000186	0.000983	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Epirubicin—bone cancer	0.000186	0.000982	CcSEcCtD
Clonazepam—Fatigue—Epirubicin—bone cancer	0.000185	0.00098	CcSEcCtD
Clonazepam—Pain—Epirubicin—bone cancer	0.000184	0.000972	CcSEcCtD
Clonazepam—Constipation—Epirubicin—bone cancer	0.000184	0.000972	CcSEcCtD
Clonazepam—Urticaria—Methotrexate—bone cancer	0.000183	0.000965	CcSEcCtD
Clonazepam—Abdominal pain—Methotrexate—bone cancer	0.000182	0.000961	CcSEcCtD
Clonazepam—Body temperature increased—Methotrexate—bone cancer	0.000182	0.000961	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000181	0.000959	CcSEcCtD
Clonazepam—Insomnia—Doxorubicin—bone cancer	0.00018	0.000952	CcSEcCtD
Clonazepam—Dyspnoea—Doxorubicin—bone cancer	0.000177	0.000938	CcSEcCtD
Clonazepam—Feeling abnormal—Epirubicin—bone cancer	0.000177	0.000937	CcSEcCtD
Clonazepam—Somnolence—Doxorubicin—bone cancer	0.000177	0.000935	CcSEcCtD
Clonazepam—Gastrointestinal pain—Epirubicin—bone cancer	0.000176	0.00093	CcSEcCtD
Clonazepam—Dyspepsia—Doxorubicin—bone cancer	0.000175	0.000926	CcSEcCtD
Clonazepam—Decreased appetite—Doxorubicin—bone cancer	0.000173	0.000915	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000172	0.000908	CcSEcCtD
Clonazepam—Fatigue—Doxorubicin—bone cancer	0.000172	0.000907	CcSEcCtD
Clonazepam—Urticaria—Epirubicin—bone cancer	0.000171	0.000903	CcSEcCtD
Clonazepam—Pain—Doxorubicin—bone cancer	0.00017	0.0009	CcSEcCtD
Clonazepam—Constipation—Doxorubicin—bone cancer	0.00017	0.0009	CcSEcCtD
Clonazepam—Abdominal pain—Epirubicin—bone cancer	0.00017	0.000899	CcSEcCtD
Clonazepam—Body temperature increased—Epirubicin—bone cancer	0.00017	0.000899	CcSEcCtD
Clonazepam—Hypersensitivity—Methotrexate—bone cancer	0.000169	0.000895	CcSEcCtD
Clonazepam—Asthenia—Methotrexate—bone cancer	0.000165	0.000872	CcSEcCtD
Clonazepam—Feeling abnormal—Doxorubicin—bone cancer	0.000164	0.000867	CcSEcCtD
Clonazepam—GABRA1—Orphan transporters—TUBB2A—bone cancer	0.000163	0.0148	CbGpPWpGaD
Clonazepam—Gastrointestinal pain—Doxorubicin—bone cancer	0.000163	0.00086	CcSEcCtD
Clonazepam—Pruritus—Methotrexate—bone cancer	0.000163	0.00086	CcSEcCtD
Clonazepam—NAT2—Biological oxidations—GSTP1—bone cancer	0.000162	0.0147	CbGpPWpGaD
Clonazepam—NAT2—Metapathway biotransformation—GSTP1—bone cancer	0.000159	0.0145	CbGpPWpGaD
Clonazepam—Hypersensitivity—Epirubicin—bone cancer	0.000158	0.000838	CcSEcCtD
Clonazepam—Urticaria—Doxorubicin—bone cancer	0.000158	0.000836	CcSEcCtD
Clonazepam—Abdominal pain—Doxorubicin—bone cancer	0.000157	0.000832	CcSEcCtD
Clonazepam—Body temperature increased—Doxorubicin—bone cancer	0.000157	0.000832	CcSEcCtD
Clonazepam—Diarrhoea—Methotrexate—bone cancer	0.000157	0.000831	CcSEcCtD
Clonazepam—Asthenia—Epirubicin—bone cancer	0.000154	0.000816	CcSEcCtD
Clonazepam—Pruritus—Epirubicin—bone cancer	0.000152	0.000805	CcSEcCtD
Clonazepam—Dizziness—Methotrexate—bone cancer	0.000152	0.000804	CcSEcCtD
Clonazepam—Diarrhoea—Epirubicin—bone cancer	0.000147	0.000778	CcSEcCtD
Clonazepam—Hypersensitivity—Doxorubicin—bone cancer	0.000147	0.000775	CcSEcCtD
Clonazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000146	0.0133	CbGpPWpGaD
Clonazepam—Vomiting—Methotrexate—bone cancer	0.000146	0.000773	CcSEcCtD
Clonazepam—Rash—Methotrexate—bone cancer	0.000145	0.000766	CcSEcCtD
Clonazepam—Dermatitis—Methotrexate—bone cancer	0.000145	0.000765	CcSEcCtD
Clonazepam—Headache—Methotrexate—bone cancer	0.000144	0.000761	CcSEcCtD
Clonazepam—Asthenia—Doxorubicin—bone cancer	0.000143	0.000755	CcSEcCtD
Clonazepam—Dizziness—Epirubicin—bone cancer	0.000142	0.000752	CcSEcCtD
Clonazepam—Pruritus—Doxorubicin—bone cancer	0.000141	0.000744	CcSEcCtD
Clonazepam—Vomiting—Epirubicin—bone cancer	0.000137	0.000723	CcSEcCtD
Clonazepam—Nausea—Methotrexate—bone cancer	0.000136	0.000722	CcSEcCtD
Clonazepam—Diarrhoea—Doxorubicin—bone cancer	0.000136	0.00072	CcSEcCtD
Clonazepam—Rash—Epirubicin—bone cancer	0.000136	0.000717	CcSEcCtD
Clonazepam—Dermatitis—Epirubicin—bone cancer	0.000135	0.000716	CcSEcCtD
Clonazepam—Headache—Epirubicin—bone cancer	0.000135	0.000712	CcSEcCtD
Clonazepam—Dizziness—Doxorubicin—bone cancer	0.000132	0.000696	CcSEcCtD
Clonazepam—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—bone cancer	0.000131	0.0119	CbGpPWpGaD
Clonazepam—Nausea—Epirubicin—bone cancer	0.000128	0.000675	CcSEcCtD
Clonazepam—Vomiting—Doxorubicin—bone cancer	0.000127	0.000669	CcSEcCtD
Clonazepam—Rash—Doxorubicin—bone cancer	0.000125	0.000663	CcSEcCtD
Clonazepam—Dermatitis—Doxorubicin—bone cancer	0.000125	0.000663	CcSEcCtD
Clonazepam—Headache—Doxorubicin—bone cancer	0.000125	0.000659	CcSEcCtD
Clonazepam—Nausea—Doxorubicin—bone cancer	0.000118	0.000625	CcSEcCtD
Clonazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000116	0.0106	CbGpPWpGaD
Clonazepam—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000115	0.0104	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—NDUFA12—bone cancer	0.000113	0.0103	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—NT5C3A—bone cancer	9.38e-05	0.00852	CbGpPWpGaD
Clonazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	9.3e-05	0.00845	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	9.27e-05	0.00842	CbGpPWpGaD
Clonazepam—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	9.18e-05	0.00834	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—DHFR—bone cancer	8.74e-05	0.00794	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—SPARC—bone cancer	7.66e-05	0.00696	CbGpPWpGaD
Clonazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	7.54e-05	0.00685	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	7.3e-05	0.00663	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.77e-05	0.00524	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.5e-05	0.005	CbGpPWpGaD
Clonazepam—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	5.29e-05	0.0048	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.27e-05	0.00479	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.98e-05	0.00452	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	4.86e-05	0.00442	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.75e-05	0.00431	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	4.64e-05	0.00421	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.61e-05	0.00419	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.55e-05	0.00413	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	4.45e-05	0.00404	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ENO2—bone cancer	4.11e-05	0.00373	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	4.08e-05	0.0037	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—CYP3A4—bone cancer	4e-05	0.00364	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.98e-05	0.00361	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	3.95e-05	0.00359	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	3.89e-05	0.00353	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	3.89e-05	0.00353	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—DHFR—bone cancer	3.81e-05	0.00346	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	3.73e-05	0.00339	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—BRAF—bone cancer	3.66e-05	0.00332	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GNA11—bone cancer	3.56e-05	0.00324	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—BRAF—bone cancer	3.49e-05	0.00317	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—GSTP1—bone cancer	3.43e-05	0.00311	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	3.4e-05	0.00309	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	3.38e-05	0.00307	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—BRAF—bone cancer	3.34e-05	0.00304	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	3.26e-05	0.00296	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP3A4—bone cancer	3.23e-05	0.00293	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	3.11e-05	0.00282	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—MDM2—bone cancer	3.06e-05	0.00278	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	2.92e-05	0.00266	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—MDM2—bone cancer	2.92e-05	0.00265	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	2.82e-05	0.00256	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—MDM2—bone cancer	2.8e-05	0.00255	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—BRAF—bone cancer	2.8e-05	0.00254	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTP1—bone cancer	2.76e-05	0.00251	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—BRAF—bone cancer	2.67e-05	0.00243	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.64e-05	0.0024	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	2.61e-05	0.00237	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	2.6e-05	0.00236	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—BRAF—bone cancer	2.56e-05	0.00233	CbGpPWpGaD
Clonazepam—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	2.45e-05	0.00223	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	2.45e-05	0.00222	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NDUFA12—bone cancer	2.4e-05	0.00218	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—MDM2—bone cancer	2.35e-05	0.00213	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.28e-05	0.00207	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—BRAF—bone cancer	2.24e-05	0.00203	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—MDM2—bone cancer	2.24e-05	0.00203	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—MDM2—bone cancer	2.15e-05	0.00195	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NDUFA12—bone cancer	2.06e-05	0.00187	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NT5C3A—bone cancer	1.99e-05	0.00181	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TP53—bone cancer	1.95e-05	0.00177	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—MDM2—bone cancer	1.88e-05	0.0017	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—SPARC—bone cancer	1.75e-05	0.00159	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NT5C3A—bone cancer	1.71e-05	0.00155	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—GNA11—bone cancer	1.6e-05	0.00145	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTP1—bone cancer	1.59e-05	0.00144	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	1.57e-05	0.00142	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IL3—bone cancer	1.45e-05	0.00132	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTGS2—bone cancer	1.43e-05	0.0013	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NDUFA12—bone cancer	1.11e-05	0.00101	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PLAU—bone cancer	9.52e-06	0.000865	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NT5C3A—bone cancer	9.23e-06	0.000838	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ENO2—bone cancer	8.71e-06	0.000791	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—DHFR—bone cancer	8.08e-06	0.000734	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GNA11—bone cancer	7.55e-06	0.000686	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ENO2—bone cancer	7.49e-06	0.00068	CbGpPWpGaD
Clonazepam—ALB—Metabolism—DHFR—bone cancer	6.95e-06	0.000631	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP3A4—bone cancer	6.85e-06	0.000622	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GNA11—bone cancer	6.49e-06	0.00059	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP3A4—bone cancer	5.89e-06	0.000535	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTP1—bone cancer	5.86e-06	0.000532	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.86e-06	0.000532	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTP1—bone cancer	5.03e-06	0.000457	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ENO2—bone cancer	4.04e-06	0.000367	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—TP53—bone cancer	3.83e-06	0.000348	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—DHFR—bone cancer	3.75e-06	0.000341	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GNA11—bone cancer	3.5e-06	0.000318	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTGS2—bone cancer	3.03e-06	0.000276	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTP1—bone cancer	2.72e-06	0.000247	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTGS2—bone cancer	2.61e-06	0.000237	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTGS2—bone cancer	1.41e-06	0.000128	CbGpPWpGaD
